Pr Yohann Loriot
- Specialty
- Oncologist, urology expert
- Title
- Deputy Head of Early Trials department
- Hospital
- Gustave Roussy (Villejuif)
- Latest articles
-
- End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer. (Sep 11, 2025)
- SGNDV-001: disitamab vedotin with pembrolizumab in HER2-expressing locally advanced or metastatic urothelial carcinoma. (Sep 1, 2025)
- A plain language summary of the TROPHY-U-01 study (Cohort 2): use of sacituzumab govitecan after immunotherapy in people with metastatic urothelial cancer who cannot take cisplatin-based chemotherapy. (Sep 1, 2025)
- Autocrine interferon poisoning mediates ADAR1-dependent synthetic lethality in BRCA1/2-mutant cancers. (Jul 29, 2025)
- Plain language summary of the THOR Cohort 1 study comparing treatment with erdafitinib or chemotherapy in advanced or metastatic urothelial cancer. (Jul 1, 2025)